The British Association for Psychopharmacology guidelines specify the scope and targets of
treatment for bipolar disorder. The third version is based explicitly on the available evidence …

A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …

Das Kompendium der Psychiatrischen Pharmakotherapie liegt jetzt in der 14. Auflage vor.
Es ist in der Nachfolge der Psychiatrischen Pharmakotherapie, die von 1974–1996 in …

We summarize evidence supporting contemporary pharmacological treatment of phases of
BD, including: mania, depression, and long-term recurrences, emphasizing findings from …

Second generation antipsychotics (SGAs) are effective options in the treatment of
schizophrenia and mood disorders, each with characteristic efficacy and safety features. In …

Background Lithium has been used clinically for 70 years, mainly to treat bipolar disorder.
Competing treatments and exaggerated impressions about complexity and risks of lithium …

Objective To identify risk factors associated with suicide of patients with schizophrenia and
provide clinical recommendations, which integrate research findings into a consensus …

Background Most longitudinal or treatment studies in bipolar disorder have used
symptomatic or syndromal status as the primary outcome variable. More recently …

Objective This study examined the risk of antidepressant-induced manic switch in patients
with bipolar disorder treated either with antidepressant monotherapy or with an …

Lithium has been the treatment of choice for patients with bipolar disorder (BD) for nearly 70
years. It is recommended by all relevant guidelines as a first-line treatment for maintenance …